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No3 (nuclear opacity 3) is a novel congenital nuclear cataract in mice. Microsatellite mapping placed the No3 locus on chromosome 1 between
D1Mit480 (32cM) and D1Mit7 (41cM), a region containing seven crystallin genes; Cryba2 and the Cryga-Crygf cluster. Although polymorphic
variants were observed, no candidate mutations were found for six of the genes. However, DNA walking identified a murine endogenous
retrovirus (IAPLTR1: ERVK) insertion in exon 3 of Cryge, disrupting the coding sequence for γE-crystallin. Recombinant protein for the mutant
γE was completely insoluble. The No3 cataract is mild compared with the effects of similar mutations of γE. Quantitative RT-PCR showed that
γE/F mRNA levels are reduced in No3, suggesting that the relatively mild phenotype results from suppression of γE levels due to ERVK
insertion. However, the severity of cataract is also strain dependent suggesting that genetic background modifiers also play a role in the
development of opacity.
© 2006 Elsevier Inc. All rights reserved.Keywords: Cataract; Crystallin; Endogenous retrovirusIntroduction
As the major macromolecular components of the ocular lens,
crystallins are centrally important to the transparency and
refractive power of the tissue [1,2]. While there may be many
different initial insults and upstream triggering events, loss of
the structural integrity and organization of crystallins is thought
to play a large part in the light scattering that causes opacity in
cataract [2].
Many crystallin-related inherited cataracts are known in
human and mouse [3,4]. The most frequently observed class of
mutation, perhaps because it has the greatest severity, results
from truncations or frame shift mutations that severely disrupt
protein structure, preventing normal folding and leading to
immediate formation of insoluble aggregates and perhaps to
amyloid [5]. Such cataracts are exemplified by Elo [6], Cat2t⁎ Corresponding author. Fax: +1 301 496 0078.
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doi:10.1016/j.ygeno.2006.12.003[7] and Nop [5] in mice. A second kind of mutation involves
more subtle mutations that allow normal three-dimensional
folding but apparently reduce thermodynamic stability or
compromise intermolecular interactions (with other proteins
or with water). This second class, exemplified by the
temperature sensitive Opj mutation in mouse γS-crystallin [8]
and several surface mutations in human γD-crystallin
[9,10,11,12,13,14], may be better models for processes in
“normal” human age-related cataract in which proteins that
were correctly folded and soluble lose their integrity and
undergo phase separation or aggregation [15,16]. In addition, it
has become clear that identical mutations in the same crystallin
gene can produce diagnostically different forms of cataract in
different human lineages [10–12], suggesting that genetic
background is important even in apparently simple mutational
models.
Here we describe a novel murine cataract, No3 (nuclear
opacity 3) which produces mild nuclear opacity that is highly
dependent upon the genetic background of the carrier mice.
Fig. 1. The appearance of the No3 opacity on the C3H/HeH background. A
nuclear opacity is visible in affected animals.
Table 1
Breeding behavior of No3/+ and No3/No3 mice
Genotype of parents Offspring Percent
cataract
Severe opacity Mild opacity +/+
No3/+x+/+ (C3H/HeH) 0 71 63 53.0
No3/+x+/+ (C57BL/6) 0 92 231 28.5
No3/+xNo3/+ 13 14 16 62.8
No3/No3+x+/+ 0 54 1 98.2
No3/No3x No3/No3 58 8 1 98.5
513N. Nag et al. / Genomics 89 (2007) 512–520Unlike most other murine crystallin mutations that have been
catalogued, No3 results from insertion of a full-length
endogenous retroviral element into the coding sequence of a
crystallin gene. This produces a frame-shifted and truncated γE-
crystallin that is superficially similar to the mutations in the




The founder animal, designated iPMS-8, resulted from
chemical mutagenesis of male (C3H/HeH×102/El)F1 mice [17]
and was said to have “nuclear opacities”. When crossed with a
normal animal it produced offspring like itself, indicating
autosomal dominant inheritance. The cataract was given the
name “nuclear opacity 3” and gene symbol No3 (Fig. 1).
Crosses of affected mice with normal animals yielded
offspring with mild diffuse opacities in the lens nucleus. When
the normal mate was from the C3H/HeH strain the ratio of
affected to normal offspring was not significantly different from
1:1 (χ2 =0.48, p>0.3). However, when affected animals were
crossed with C57BL/6 there was a severe shortage of affected
animals (χ2 =59.8, p<0.001) (Table 1). The probable explana-
tion of this shortage was incomplete penetrance. There may
have been some misclassification of No3/+ as normal offspring
in the C3H/HeH crosses also as the phenotype was sometimes
very mild. When two affected animals were crossed together
some offspring showed a more severe phenotype, and were
suspected to be homozygotes. When these animals were crossedFig. 2. Schematic of the candidate genes for No3 on mouse chromosome 1. The mapp
Cryga–Crygf cluster. Not to scale.to C3H/HeH, almost all offspring showed the mild phenotype of
No3/+, confirming the parents to be No3/No3. Crosses of No3/
No3 animals together yielded almost all offspring with the more
severe phenotype of No3/No3.
Histological examination of eyes from new born and adult
No3/No3 mice showed no obvious deviations from normal lens
size or organization (not shown).
Mapping
Preliminary results with markers covering the whole genome
showed significant linkage with the marker D1Mit46 (χ2=10.7,
p<0.01) (data not shown). The same animals were then typed for
several more markers on Chromosome 1. A few animals gave
anomalous results suggesting misclassification for No3 and these
were excluded. Results from the remaining 41 mice gave the
following recombination percentages: D1Mit3–17.6±6.2–
D1Mit213–12.2±5.1–(D1Mit282, D1Mit480, No3) –2.4±2.4–
(D1Mit7, D1Mit181, D1Mit46)–4.1±3.4–D1Mit80–21.9+6.5–
D1Mit227. These results place the No3 locus between
D1Mit480 at 32cM and D1Mit7 at 41cM, thus making both the
Cryg cluster at 32cM and Cryba2 at 40.8cM possible candidate
genes (Fig. 2).
Candidate gene analysis
Prior to the availability of the complete mouse genome
sequence, the CrybA2 gene from No3 was examined by PCR
amplification of genomic DNA using primer sequences based
on the published mouse cDNA sequence. No coding sequence
mutations were found. The structure of the CrybA2 gene will be
described separately. In addition, a cDNA library was
constructed from adult No3 mouse eyes. Since the No3
background contained the rd gene, this provided an example
of a retinal degeneration model to add to the NEIBank database
of eye-expressed genes (http://neibank/nei.nih.gov). It alsoed interval contains genes for seven crystallins: Cryba2 and the six genes of the
Fig. 3. PCR and Gene Walking strategy for Cryge in No3. Schematic of wild type Cryge structure with exons shown as boxes (not to scale). Small arrow pairs indicate
regions amplified directly from genomic DNA, with +/− indicating success or failure. Thick arrows indicate the regions examined by Gene Walking using nested gene
specific and degenerate primers.
514 N. Nag et al. / Genomics 89 (2007) 512–520provided full length cDNA sequences for βA2, γB, γC and γD-
crystallins from No3/No3. These all appeared to be normal,
matching the sequences for C57BL/6, with one exception. The
predicted amino acid sequence of γD from No3 has 52A
(counting from the initiator codon), instead of 52T found in
C57BL/6. However this difference is also seen in another mouse
strain (GenBank accession NP_031802) and may therefore
represent a common polymorphism.Fig. 4. Retroviral insertion in Cryge. (a) Schematic of exon 3 of Cryge in No3. The in
ERV-K insert in red (not to scale). The direct repeat GGCGGC sequences are indicat
and red line shows the ORF of the read through transcript into the LTR. (b) Sequenc
Cryge exon 3 is in black and LTR sequence is in red. The read through ORF producin
comparison of C57BL/6 wild type, No3, Elo and Cat2t γE crystallins. The complet
structural motifs (I 1–39; II 40–81; Connecting peptide between domains 82–86; III 8
positions of the four β-strands. Below the wild type sequence are shown the C-termin
the second motif of γE from No3.No cDNA clones were observed for γA, γE or γF-crystallins
in this EST analysis. These were addressed by PCR amplifica-
tion of exons from genomic DNA using primers based on
C57BL/6 genome sequence and by RT-PCR of RNA extracted
from adult No3 and FVBN mouse eyes. All three genes were
successfully amplified from the control DNA, but only γA and
γF were obtained from No3. Exons and flanking regions were
sequenced from the γA and γF amplimers. Several apparentterrupted ORF sequence of exon 3 is shown in yellow (3′ UTR in blue) and the
ed. Yellow lines indicate the (broken) ORF of exon 3 and below that, the yellow
e at the 5′ (above) and 3′ (below) ends of the ERV-K insertion. (c) Sequence for
g the mutant γE sequence is shown translated below the 5′ sequence. Sequence
e wild type sequence is shown arranged in four lines corresponding to the four
7–127; IV 128–173). Above the sequence for the fourth motif, arrows show the
al truncations of the different mutants. Also shown is the A51T polymorphism in
Fig. 5. The ERV insertion is a de novo mutation in No3. a) Genomic PCR of Wt
Cryge third exon (upper panel) and No3 ERV insertion (lower panel) from No3
and other mouse strains. M: size markers; 1:No3/+; 2: No3/No3; 3: +/+
littermates (from No3/+ mating); 4: C3H (IMG, Germany); 5: 102 (IMG,
Germany); 6: 102 (MRC, UK); 7: C3H (MRC, UK); 8: FVBN; 9: No DNA
control. The Wt allele is missing only from No3/No3 and the mutant allele is
present only in No3/No3 and No3/+. b) The mutant γE-No3 transcript is
expressed. RT-PCR of No3 eye RNA with intron crossing primers for the
complete mutant coding sequence.
Fig. 6. Mutant γE-No3 is insoluble. Expression of recombinant WT γE and γE-
No3. Upper panel shows SDS PAGE, lower panel shows Western blot using
antiserum to γ-crystallin. M: Size markers. Ins and Sol designate insoluble and
soluble fractions of whole cell lysate from E.coli expressing either WT or No3
recombinant protein. Recombinant γE-No3 is found only in the insoluble
fraction.
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sequence in intron 2 were observed in Cryga, but none that
were plausible candidates for the No3 mutation. For Crygf,
three sequence differences with C57BL/6 were observed in
exon 3, although all three were identical with the 129SV/j
genomic sequence. Two of these were silent, but the third
resulted in a predicted difference of G165S compared with the
amino acid sequence of C57BL/6. This also appeared to be a
strain related polymorphism that might contribute to back-
ground susceptibility but was not thought to be a likely
candidate for the No3 mutation. γA and γF coding sequences
were confirmed by RT-PCR of No3 eye RNA. Again, no
product was obtained for γE using sequence specific primers.
The Cryge gene was then amplified in sections. Exons 1 and
2 and flanking sequences were amplified in one piece and
sequenced (Fig. 3). Sections of intron 2 and 3′ flanking
sequence were also amplified and sequenced. One apparent
polymorphism was identified in exon 2 that would lead to an
A>T amino acid change at position 51 in the mature protein
(Fig. 4c) relative to the C57BL/6 sequence, however T at this
position has also been observed in γE sequences from other
strains (for example [18]) and the A/T polymorphism appears in
both γE and γF of different strains in GenBank.
No PCR product was obtained for Cryge exon 3. This
suggested the presence of a large deletion, insertion or
rearrangement in exon 3. To map the unknown sequence of
exon 3, gene walking was used. This is a procedure that uses
known, specific primers (in this case taken from known intron 2
and 3′ flanking sequence) in successive amplifications with
overlapping degenerate primers [19]. Products were success-
fully obtained for both sense and antisense directions, mappingthe site of the disruption in exon 3 sequence. Sequence analysis
showed that exon 3 was interrupted by a murine endogenous
retrovirus (ERV-K), with intact LTR sequences at both ends and
a duplicated GGCGGC hexamer at the insertion site (Fig. 4a).
The complete ERV-K insertion was cloned by PCR from
No3 genomic DNA and sequenced (GenBank Acces-
sionDQ864756). The insertion is a full-length ERV-K element,
5 kbp in length, flanked by identical LTRs of 354 bp and
containing a full ORF for a gag/pol gene. The closest matches
of this new element in the C57BL/6 genome are two ERV-K
elements on mouse chromosome 16. Either of these may be the
progenitor of the new element, or it could be derived from a
different element in the C3H/HeH strain. Genotyping for wild
type and No3 Cryge in No3/No3, No3/+ and +/+ littermates
(from No3/+ matings), from parental C3H and 102 strains (from
both MRC and IMG colonies) and from FVBN mice showed
that this is a de novo mutation in No3 (Fig. 5a).
The retroviral insertion occurs after codon 142 of the ORF
(Figs. 4b,c). Read through into LTR sequence provides 14 more
in frame codons before a stop codon. γ-crystallins consist of
two domains, each made from two repeated structural motifs
[20,21]. In No3, γE has a normal N-terminal domain and a
normal third motif. However, the fourth motif is truncated and
would not be able to complete the C-terminal domain. This
would prevent normal formation of intra-domain β-sheets and
could also expose hydrophobic core residues of the C-terminal
domain. RT-PCR from No3 eye RNA amplified the complete
coding sequence (crossing 2 intron positions), demonstrating
that the mutant mRNA is expressed (Fig. 5b).
Recombinant protein
To examine the effects of the mutation on the protein, the
complete γE-No3 coding sequence was amplified from RT-PCR
product and cloned into pET31b for expression in E.coli (Fig.
516 N. Nag et al. / Genomics 89 (2007) 512–5206). The WT coding sequence of γE from FVBN lens (with the
51T polymorphism common to No3) was also cloned and
expressed. For the WT sequence, much of the recombinant
protein was found in the soluble fraction, while some was also
retained in inclusion bodies, as is typical for γ-crystallin
expression in this system (Fig. 6). In contrast, although γE-No3
expressed well, western blotting showed that all of theFig. 7. Suppression of γE/F transcript levels in No3. (a) RT-PCR of transcripts for γA
No3/+ x No3/+ matings). (b) QPCR of transcripts for γA, γD and γE/F crystallins in N
γE/F RNA from wild type and No3/No3 lens at three dilutions of template. The shift i
target γE/F RNA levels.expressed protein was in the insoluble fraction (Fig. 6). The
identity of the insoluble band was confirmed by mass spectro-
scopy of tryptic digests which identified peptides covering more
than half of the protein sequence for the mutant γE and by
electrospray mass spectroscopy which identified a major
species with relative mass 18806 Da, in agreement with the
predicted size for the mature mutant protein. Attempts were(upper band) and γE (lower) crystallins in +/+, No3/No3 and No3/+ lenses (from
o3/No3 and +/+ lenses A: Tc curves for amplification of (A) γA, (B) γD and (C)
n cycle number of the crossing point for the No3 samples indicates a reduction in
517N. Nag et al. / Genomics 89 (2007) 512–520made to denature and refold the insoluble protein but no soluble
product was obtained.
Examination of γE-No3 transcript levels
RT-PCR was used to give a semi-quantitative comparison of
expression levels for γA and γE-crystallin mRNAs in eyes of
No3/No3, No3/+ and +/+ mice (from No3/+ x No3/+ matings)
(Fig. 7a). Levels for γA were similar in all three genotypes.
Levels for γE appeared lower in No3/No3 mice. Furthermore,
although the PCR primers were designed to exploit the limited
sequence differences between γE and γF, it was not possible to
verify that only γE was being amplified.
To address this issue more quantitatively, quantitative RT-
PCR (Q-PCR) was used (Fig. 7b). It was determined that
transcripts for both γA and γD were present in equivalent
amounts in wild type and No3/No3 mice. Again, this method
was unable to reliably distinguish between the very similar γE
and γF transcripts. However, using γA as a reference, Q-PCR
showed that the sum of combined γE and γF transcripts
detected in No3/No3 eye was reduced to approximately 50% of
the wild type levels. This suggests that there is a substantial drop
in the level of γE mRNA in No3.
Discussion
Several models of inherited cataract in mice have been
created by chemical or radiation mutagenesis [3,22,23]. Many
of these are associated with single base changes or small
insertion/deletions that modify the coding sequence of one of
the crystallins, the major soluble proteins of the eye lens. No3 is
a nuclear cataract observed in a chemical mutagenesis study.
The causative mutation was localized to the region of mouse
chromosome 1 that contains the genes for βA2-crystallin and
the cluster of six genes for the γA-F-crystallins. Since mutations
in murine γ-crystallin genes often produce severe phenotypes,
this raised the interesting possibility that No3 could be the first
example of a mutation in βA2-crystallin. However, this proved
not to be the case and, surprisingly, considering the reported
severity of similar mutations [6,7], No3 was found to be
associated with a fourth motif truncation mutation of γE-
crystallin. In the generally similar Elo and Cat2t truncation
mutants, lens fiber cell necrosis and microophthalmia have been
reported [6,7], while the No3/No3 lens appears superficially
normal in organization and only exhibits a nuclear opacity.
Furthermore, the severity of this opacity is variable and strongly
strain-dependent.
It was also surprising to find that the cause of themutationwas a
probably spontaneous insertion of a full-length murine endogen-
ous retrovirus, rather than chemical mutagenesis. Endogenous
retroviruses (ERV) make up a large fraction of the mammalian
genome [24,25]. While the majority of the ERV elements are
incomplete and apparently inactive, some full-length copies exist
andmay give rise to daughter elements that can insert elsewhere in
the genome. In mice, the major class of actively transposing ERV
elements is known as intracisternal A particles (IAP), and those
with long terminal repeats also carry the designation for LTR. Thefrequency of IAP/ERVinsertion varieswithmouse strain; themost
susceptible strain being C3H/He [24].The 5kbp insertion in the
Cryge gene in No3 belongs to the ERV-K class of IAPLTR1
transposons [24–26], with a perfectly conserved 354bp LTR at
both ends and a characteristic direct repeat (GGCGGC) at the
insertion site. Genotyping confirmed that this insertion is unique to
No3 and was not present in parental strains.
The ERV insertion into exon 3 of Cryge disrupts the coding
sequence of γE-crystallin approximately half way through the
fourth and final “Greek-key” like motif of the protein at codon
142, after the first β-strand of the motif but eliminating the final
threeβ-strands needed to complete the structure of theC-terminal
domain [20,21] (Fig. 4). The open reading frame continues into
the ERV LTR sequence for a further 14 codons. Thus the γE
polypeptide in No3 is longer than the truncated mutants of Elo
and Cat2t (which are also fourth motif truncations of γE) and is
potentially able to form an additional β-strand. The No3 mutant
protein would not be able fold correctly andwould be expected to
be entirely insoluble. However, since the severity of the No3
cataract was so different from that reported for Elo and Cat2t, we
considered the remote possibility that the apparent differences in
the effects of the mutant proteins might be due to altered folding,
or even formation of multimers, that might permit at least partial
solubility for No3.
To test the solubility issue, recombinant γE-No3 was
expressed in E.coli. The protein expressed well, but, in contrast
to wild type FVBN γE, was undetectable in the soluble fraction.
Attempts were made to denature and refold the insoluble protein
but no solubilization was achieved. This suggests that the No3
mutant γE is indeed completely insoluble and no more
functional in the lens than its counterparts in the other cataract
models. There is still the possibility that the mild phenotype in
No3 is due to a difference in the aggregation properties of the
mutant γE (perhaps a reduced tendency for amyloid formation).
However other more likely explanations for the mild phenotype
are available.
Quantitation of transcript levels inNo3 shows that expression
of the mutant Cryge gene is suppressed. Retroposons,
particularly those with LTR sequences, can suppress expression
of nearby genes, either transcriptionally or post-transcriptionally
[24,25]. Quantitative RT-PCR of crystallin gene transcripts from
+/+ and No3/No3 littermates showed that levels of mRNA for
γA and γD were similar but that the combined level of mRNA
for the highly similar γE and γF-crystallins (indistinguishable in
this assay) was significantly reduced. Since Crygf (the γF gene)
is normal in sequence and is also the most distantly located
member of the γ-crystallin gene cluster from the mutated Cryge
(Fig. 2), it is unlikely that its level of mRNA is significantly
affected. This suggests that the level of mRNA for γE is very low
in the No3/No3 lens. This may act to offset the severity of the
No3 mutation at the protein level by reducing the amount of
insoluble, aggregated protein in the lens fiber cells.
Opacity due to No3 may be the result of insolubilization of
the mutant protein and/or to loss-of-function of γE-crystallin.
Indeed, a possible functional interaction for γE-crystallin with
the major lens membrane protein MIP/APQ0 has recently been
reported [27]. No3/No3 mice may be close to a “knock out” or
518 N. Nag et al. / Genomics 89 (2007) 512–520“knock down” of γE that could be used to further investigate its
role and to shed some light on the functional basis for the loss of
γE expression as part of a suite of molecular changes in the
evolution of the human lens [28,29].
The severity of cataract associated with the No3 mutation is
also affected by differences in genetic background. This is
illustrated by the incomplete penetrance of No3 in C57BL/6
matings, which suggests that another genetic variant in the C3H/
HeH strain is required for formation of an obvious opacity. In other
words the No3 mutation alone is not sufficient for severe
opacification of the lens but combines with some modifier that
itself does not produce cataract in isolation. For example, it is
possible that a coding sequence polymorphism exists in C3H/HeH
that compromises the solubility or function of another lens protein
but is ameliorated by normal levels of wild type γE, perhaps by
direct protein-protein interaction. Loss of γE, whether by
insolubilization or suppression, might then lead to loss of function
or increased insolubilization of the partner protein, increasing the
severity of opacity due to mutant γE alone. In strains that lack the
modifier, such as C57Bl/6, the effects of the No3 mutation on γE
would have a milder phenotype than in the C3H/HeH parental
strain.
One possible modifier for lens phenotypes has recently been
observed in mice of the 129 strain families. This involves a
truncation and loss of the major lens cytoskeleton protein
Bfsp2/CP49 [30]. No3/No3 mice on the original background
were genotyped for the known CP49 mutation but only wild
type alleles were observed, suggesting that at least one other
genetic variant capable of modifying lens function or severity of
cataract exists in laboratory mouse strains and awaits discovery.
Many simple mutations in crystallins have been associated
with severe inherited cataract in both humans and mice. However,
these results show that in some cases the crystallin mutation may
be just the final step in amultifactorial process, with the phenotype
and severity of the cataract dependent also on genetic background
and environment. Such a multi-step progression towards cataract
may be similar to what happens in human age related cataract, as
accumulating post-translational modifications in the aging lens
interact with polymorphic variant sequences, eventually produ-




The original animal was found at the Institute of Mammalian Genetics,
Neuherberg, Germany, among the offspring in an experiment in which male
mice of genotype (C3H/HeH×102/El)F1 were treated with the mutagen iso-
propyl methane sulphonate, and their offspring were scored for eye defects [17].
The mutant was transferred to the Medical Research Council, Harwell,
Oxfordshire, UK, and given the name “nuclear opacity 3” and gene symbol
No3. All studies were performed under the guidance issued by the Medical
Research Council and Home Office licenses 30/1517 and 30/2049.
Phenotype screen
Mice aged 4-6 weeks were scored for cataracts by slit-lamp examination
(Zeiss 30SL/M) at 20x magnification with illumination at a 25–30° angle fromthe direction of observation. Dilatation of the pupil was achieved with 1%
atropine sulphate (Schering-Plough) applied at least 10 minutes before
examination.
Mapping
No3/+ mice were crossed to C57BL/6 and affected offspring were
backcrossed to C3H/HeH. Backcross offspring were scored for cataract, and
were then typed for microsatellite markers spaced at ∼20cM intervals
throughout the genome. When linkage was found the same animals were
typed for additional markers in the region of interest. DNAwas extracted from
tail tissue and PCR conditions were as described [31].
Expressed sequence tag analysis
Twenty eyes from adult No3/No3 mice were extracted with RNAzol (Tel-
Test Inc., Friendswood, TX), yielding 1133 μg of total RNA. 11.3 μg of twice
selected polyA+ RNA cDNA was prepared by oligo(dT) cellulose affinity
chromatography of which 5 μg was used to synthesize cDNA using the
Superscript II system (Invitrogen, Carlsbad CA). The cDNA was cloned into
the Sal I-Not I sites of the pCMVSport6 vector (Invitrogen), essentially as
described before [32,33]. The unamplified library was cloned as two
sublibraries, designated ob and oc, that were combined for subsequent se-
quence analysis. Library construction was carried out at Bioserve Biotechno-
logies (Laurel, MD).
Clones were randomly selected for sequencing at the NIH Intramural
Sequencing Center, as described before [32]. Just over 2800 clones were
sequenced, with average read length of 597nt. Sequence data from the expressed
sequence tag (EST) analysis of all libraries were processed for quality and to
remove vector and other non-cDNA sequences as described previously [34].
Insert sequences were analyzed using GRIST [35] to group and identify
sequences. 2500 high quality reads were obtained after trimming and removal of
mitochondrial and other contaminant sequences. Data are available through
GenBank and at http://neibank.nei.nih.gov/cgi-bin/showDataTable.cgi?
lib=NbLib0074.
PCR methods
Primers were designed from C57BL/6 genome sequence to amplify specific
candidate genes from genomic DNA from No3/No3 and wild type FVBN mice
using the Fast Start High Fidelity PCR system (Roche, Indianapolis IN). Primers
for Cryga: MGA1: ACACTGACCATTTGCTGTCAACAAC; MGA2: GAT-
TATTTATTGCATATATGGGCTG. For Cryge and Crygf, a common sense
primer: MGEDF1: TCCCATCCGACCTGCCAACACCAGC; and specific
antisense primers: MGE2: TTATTACTGTCCAGATGGAGAAAAT; MGF2:
ATTAACTTCCAAATGATGAAAGGGC; were used. Several more primer sets
were then used to amplify exons 1 and 2 of Cryge from No3, intron 2 sequences
and 3’ flanking sequences.
The DNA Walking SpeedUp Premix Kit (Seegene Inc., Seoul Korea) was
used to amplify unknown sequence in exon 3 from both 5′ and 3′ sides using









Primers MGEX3.S and NAS173234 were also used to amplify the complete
ERV insertion using the Expand Long range PCR kit (Roche) for subsequent
cloning using the Expand Cloning kit (Roche). To produce a subclone lacking
LTR sequence primers LTR1: GTGGTGTTCTTCCTGGCCGGTCGTGAG;
LTR2: TCTGCGGCAAAGCTTTATTCTTACATC; were used.
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CTCGAGTCATGCGCAGATTATTTTGTTTAC. The wild type allele was
genotyped using MGEX3.S and WTEX3AS: GCCCTTCAATTGAGGGT-
GAAAGGAACAG. Mice were also genotyped for a known Cp49 mutation
found in mouse 129 strains as described [30].
Genomic DNA sequence
PCR derived fragments were sequenced using the Beckman CEQ 2000
system (Beckman Coulter, Fullerton CA). The ERV insertion was partially
sequenced in house and completed with primer walking at Agencourt (Beverly
MA).
Recombinant protein
The coding sequence of No3 mutant mouse γE was cloned by PCR from
cDNA template generated by RT-PCR from No3 eye RNA using primers GEN1:
CATATGGGGAAGATCACCTTCTATGAGG and GENXho1: CTCGAG-
TCATGCGCAGATTATTTTGTTTAC. WTwas cloned in a similar, substituting
GEWTX: CTCGAGTCAATAGAAATCCATGATTCTCCT as 3′ Xho-contain-
ing primer. Clones were confirmed by sequencing and cloned into Nde I/Xho I
sites of pET 31b (Novagen). Each plasmid was transformed into E.coli BL21
(DE3) pLysS (Novagen). Induction yielded high expression of both proteins.
For protein isolation, the pellet was thawed, sonicated and centrifuged at
15000 g for 20 minutes at 4°C. Soluble and insoluble fractions were examined
by SDS PAGE and western blotting. The antibody used was a polyclonal against
purified recombinant human γD-crystallin [9] raised in rabbits at Spring Valley
Labs (Woodbine, MD).
Mass spectroscopy
The recombinant protein was also confirmed by mass spectroscopy. For
tryptic peptide mapping, whole cell lysate, ∼50 μg, was separated by SDS-
PAGE. The over-expressed recombinant protein band was excised from the
stained gel and digested with trypsin (1:100) (Promega) according to
manufacturer's protocol. Peptides were extracted, reduced, alkylated and
dried. Extracts were resuspended, applied to zip-tip columns (Millipore),
spotted in the presence of cyano-hydroxycinnamic acid (Sigma) and analyzed
using MALDI (Voyager, Applied Biosystems) in reflector mode, delayed
extraction mode with 68% grid voltage and a 700 nsec delay.
Protein was also sized using Electrospray liquid chromatography–mass
spectrometry. The LC-MS system consisted of an Agilent (Palo Alto, CA)
binary pump, degasser, autosampler, and an HP1100 Mass Selective Detector
(MSD). Data were acquired on the HP ChemStation data system. The instrument
was calibrated with a standard Agilent ES tuning mix. The mass spectrometer
was scanned from m/z 500 to 2000 every four seconds. Nitrogen was used to
assist nebulization and desolvation. Solvent A of the mobile phase consisted of
5% (v/v) acetic acid, solvent B consisted of 100% acetonitrile. After an initial
wash phase of 25 min at 5% solvent B, chromatographic separation was done
using a gradient from 5 to 95% solvent B within 25 min at 40°C on a Zorbax SB-
C3 reversed phase column (150 mm×2.1 mm ID) and a C3 guard column at a
flow rate of 0.2 ml/min. The injection volume was 100 μL equaling
approximately 25 pmol of protein.
Refolding
Inclusion bodies containing γE-No3 were purified from E. coli whole cell
lysate by centrifugation. The recombinant protein was dissolved in guanidinium,
8 M and DTT 4 mM. The dissolved protein was then added drop-wise to
refolding buffer: Tris100 mM, L-arginine 400 mM, EDTA 3 mM, oxidized
glutathione 0.5 mM and reduced glutathione, 5 mM. The suspension was gently
stirred overnight at 4°C, dialyzed in Tris, 50 mM.
Q-PCR
The mRNA from equal quantities of wild type and No3 mouse total RNA
was converted to cDNAvia reverse transcription as per protocol using the RocheTranscriptor First Strand cDNA Synthesis Kit. Ten-fold dilution series of the
cDNAs were made for four orders of magnitude.
Quantitative PCR was performed using a Roche LightCycler and Universal
ProbeLibrary hybridization probes (Roche). Using the ProbeFinder software
from Roche (available at the Assay Design Center, http://www.universalprobe-
library.com) we designed primer and probe pairs to assay transcripts fromCryga,
Crygd, Cryge, Crygf, and also from Alas and Gapdh genes (serving as low and
high expressing “housekeeping” genes). Due to the high degree of sequence
similarity, the assays could not distinguish between Cryge and Crygf.
Amplification and detection of the transcripts was performed following the
protocols of the LightCycler TaqMan Master Reagent kit (Roche).
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